Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T19:21:57.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to related updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-24T19:22:54.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer version changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T22:04:03.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, reflecting a minor update to the website platform.
    Difference
    0.1%
    Check dated 2026-10-10T22:06:07.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The history view now shows a newer revision identifier (v3.7.0) replacing the older v3.6.6, indicating an update to the page's revision history rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-09-19T20:59:06.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the history and the previous revision v3.6.5 was removed from the visible list. This updates the versioning record for the page without modifying the study data or status.
    Difference
    0.1%
    Check dated 2026-08-29T18:28:17.000Z thumbnail image

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.